Shen C. Andrew

Andrew C. Shen

Education

  • Columbia Law School, J.D., 2004
    • James Kent Scholar, 2002-2003
    • Harlan Fiske Stone Scholar, 2004
    • Charles Bathgate Beck Prize
    • Member, Columbia Law Review, 2002-2004
  • Cornell University, B.A., with Distinction, 2000

Clerkships

  • Law Clerk, Judge Dolores K. Sloviter, U.S. Court of Appeals, Third Circuit, 2004-2005

Admitted

  • 2005, New York
  • 2006, District of Columbia

Andrew C. Shen guides plaintiffs and defendants at the trial and appellate levels in a wide array of matters, including breach of contract, securities, antitrust, health care, fraud, telecommunications, and whistleblower litigation.

Andy’s clients include Fortune 200 companies, whistleblowers, institutional investors, foreign sovereigns and officials, and the first federal financial institutions regulator to recover losses from the sale of faulty residential mortgage-backed securities. To date, he has recovered more than $6 billion for his clients and successfully defended clients against similarly large damages claims.

Representative Experience

  • United States ex rel. Scott v. Humana – Lead counsel representing a whistleblower in a False Claims Act action against an insurance company.
  • Representing foreign sovereigns and foreign officials in numerous cases throughout the country.
  • National Credit Union Administration – Represented the National Credit Union Administration as liquidating agent in a series of lawsuits against 18 financial institutions regarding the sale of residential mortgage-backed securities.  More than $5.1 billion has been recovered.
  • CUNA Mutual Group – Represented an insurance company in a series of lawsuits regarding the sale of residential mortgage-backed securities.
  • Bank of New York Mellon Corp. Forex Foreign Exchange Transactions Litigation – Defended The Bank of New York Mellon in litigation and investigations challenging foreign exchange services provided to customers.  Obtained voluntary dismissals of all Securities Act claims.
  • United States ex rel. Westmoreland v. Amgen Inc.– Represented a whistleblower
    in a False Claims Act action against a drug manufacturer and Group Purchasing Organization.  This matter was litigated in both the United State District Court for the District of Massachusetts and the United States Court of Appeals for the First Circuit.  On the eve of trial, a global settlement was reached with defendants for $750 million.
  • In re Guidant Corp. Implantable Defibrillators Products Liability Litigation – Represented plaintiffs in a medical device products liability litigation.  Defendant settled this matter for $240 million.

 

 

Achievements

  • Lawdragon 500 Leading Litigators in America – 2023 and 2024
  • Benchmark Litigation – Litigation Star for Competition / Antitrust & Securities
  • Benchmark Litigation – Inaugural Hot 40 Under 40

News